Managing the uninvestigated dyspeptic patient.
Farup
P G
PG
D000900:Anti-Bacterial Agents / Q000191:economics / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D004415:Dyspepsia / Q000191:economics / Q000382:microbiology / Q000628:therapy*; D016481:Helicobacter Infections / Q000175:diagnosis*; D016480:Helicobacter pylori / Q000302:isolation & purification*; D006801:Humans
D000900:Anti-Bacterial Agents